Table 3 BAP1 immunoreactivity in cytological and cell-block samples
Diagnosis | No. of cases | BAP1 loss (%) |
|---|---|---|
Benign mesothelial reaction | 17 | 0/17 (0) |
 Inflammatory | 15 | 0/15 (0) |
 Lung adenocarcinoma | 2 | 0/2 (0) |
Malignant mesothelioma | 45 | 29/45 (64) |
Atypical mesothelial cells of indeterminate origin | 8 | 6/8a (75) |